1. 458PMutation tracking in circulating tumour DNA predicts relapse in completely resected EGFR-mutated NSCLC. (24th November 2019) Authors: Filipits, M; Hochmair, M J; Buder, A; Watzka, S Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 495PTracking of activating EGFR mutations predicts progression-free survival in advanced EGFR-mutated NSCLC patients treated with osimertinib. (24th November 2019) Authors: Buder, A; Hochmair, M J; Setinek, U; Filipits, M Journal: Annals of oncology Issue: Volume 30(2019)Supplement 9 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗